In focus: Michael Lewis

Michael Lewis tests potential new drugs in mouse models of human psychiatric disease. His work helps meet a major challenge of treating psychiatric disease: The field lacks a firm understanding of the biology underlying such diseases as schizophrenia, bipolar disorder, or depression. Hear him describe his work as a research scientist in the Stanley Center for Psychiatric Research at the Broad Institute.